The present invention is directed to the area of implantable electrical stimulation systems and methods of making, using and implanting the same. More specifically, the present invention is directed to systems and methods for leads that provide electrostimulation to peripheral nerves and other target tissues, as well as methods of making, using and implanting the leads and electrical stimulation systems.
Implantable electrical stimulation systems have proven therapeutic in a variety of diseases and disorders. For example, spinal cord stimulation systems have been used as a therapeutic modality for the treatment of chronic pain syndromes. Peripheral nerve stimulation has been used to treat chronic pain syndrome and incontinence, with a number of other applications under investigation. Functional electrical stimulation systems have been applied to restore some functionality to paralyzed extremities in spinal cord injury patients. Stimulation of the brain, such as deep brain stimulation, can be used to treat a variety of diseases or disorders.
Stimulators have been developed to provide therapy for a variety of treatments. A stimulator can include a control module (with a pulse generator), one or more leads, and an array of stimulator electrodes on each lead. The stimulator electrodes are in contact with or near the nerves, muscles, or other tissue to be stimulated. The pulse generator in the control module generates electrical pulses that are delivered by the electrodes to body tissue.
One embodiment is an electrical stimulation lead that includes at least one lead body having a distal end portion, a proximal end portion, and a longitudinal length. The lead further includes a paddle body extending from the distal end portion of the at least one lead body, electrodes disposed along the paddle body, terminals disposed along the proximal end portion of the at least one lead body, and conductors electrically coupling the terminals to the electrodes. The lead further includes an anchoring device threadably disposed in at least a portion of the paddle body. The anchoring device has a head element and a tissue-engagement element fixed to the head element such that actuation of the head element urges the tissue-engagement element away from or toward the paddle body.
In at least some embodiments, the paddle body includes a protuberance extending from a remainder of the paddle body and at least a portion of the anchoring device is disposed in the protuberance. In at least some embodiments, the head element includes a recessed region configured to be engaged by a tool. The recessed region can be hexagonally.
In at least some embodiments, the lead includes at least one additional anchoring device threadably disposed in a different portion of the paddle body.
In at least some embodiments, the tissue-engagement element is a helical member. The anchoring device is disposed along a side portion of the paddle body, the anchoring device is disposed along an end portion of the paddle body, or some combination thereof.
In at least some embodiments, the paddle body includes a curved section located between the anchoring device and at least one additional anchoring devices. The curved section is configured for placement over a target tissue.
Another embodiment is an electrical stimulation lead for stimulating a target tissue that includes a lead body having a distal end portion, a proximal end portion, and a longitudinal length, electrodes disposed along the distal end portion of the lead body, terminals disposed along the proximal end portion of the lead body, and conductors electrically coupling the terminals to the electrodes. The distal end of the lead body includes a helical shape that variably locates the electrodes around the target tissue in both a longitudinal and circumferential direction.
In at least some embodiments, the lead includes a stylet extending through at least the distal end of the lead body. The stylet can be helically shaped nitinol wire.
In at least some embodiments, the distal end of the lead body is molded into the helical shape.
In at least some embodiments, the lead includes a sheath located over at least a section of the distal end portion of the lead body. And, the sheath may include a slit for sliding the sheath over the lead body and the target tissue.
A further embodiment is a method of implanting an electrical stimulation lead that includes the steps of (1) moving a distal end portion of the lead described above to be within a vicinity of a target tissue; (2) from a proximal end portion of the lead, inserting a stylet longitudinally into the lead, where a distal end portion of the stylet includes a helical shape; and (3) manipulating the stylet to urge the distal end portion of the lead to helically wrap around the target tissue. Inserting the stylet may include inserting a nitinol guidewire.
Yet another embodiment is an electrical stimulation lead that includes at least one lead body having a distal end portion, a proximal end portion, and a longitudinal length, a paddle body extending from the distal end portion of the at least one lead body, electrodes disposed along the paddle body, terminals disposed along the proximal end portion of the at least one lead body, and conductors electrically coupling the terminals to the electrodes. The lead further includes an anchoring element manipulatable to extend through at least a portion of the paddle body. The anchoring element has a distal end portion adaptable to become a tissue-engaging element when the distal end portion is urged out of the paddle body.
A further embodiment is an electrical stimulation system that includes any of the leads described above and a control module coupleable to the lead. The control module includes a housing and an electronic subassembly disposed in the housing. The lead further includes a connector for receiving the electrical stimulation lead, the connector having a proximal end, a distal end, and a longitudinal length. The connector includes a connector housing defining a port at the distal end portion of the connector. The port is configured and arranged for receiving the proximal end portion of the lead body of the electrical stimulation lead. The connecter further includes connector contacts disposed in the connector housing. The connector contacts are configured and arranged to couple to at least one of the terminals disposed on the proximal end portion of the lead body of the lead. In at least some embodiments, the lead includes a lead extension coupleable to both the lead and the control module.
Non-limiting and non-exhaustive embodiments of the present invention are described with reference to the following drawings. In the drawings, like reference numerals refer to like parts throughout the various figures unless otherwise specified.
For a better understanding of the present invention, reference will be made to the following Detailed Description, which is to be read in association with the accompanying drawings, wherein:
The present invention is directed to the area of implantable electrical stimulation systems and methods of making, using and implanting the same. More specifically, the present invention is directed to systems and methods for leads that provide electrostimulation to targets such as peripheral nerves, as well as methods of making, using and implanting the leads and electrical stimulation systems.
Suitable implantable electrical stimulation systems include, but are not limited to, a least one lead with one or more electrodes disposed along a distal end of the lead. Leads include, for example, percutaneous leads, paddle leads, and cuff leads. Examples of electrical stimulation systems with leads are found in, for example, U.S. Pat. Nos. 6,181,969; 6,516,227; 6,609,029; 6,609,032; 6,741,892; 7,203,548; 7,244,150; 7,450,997; 7,596,414; 7,610,103; 7,672,734; 7,761,165; 7,783,359; 7,792,590; 7,809,446; 7,949,395; 7,974,706; 6,175,710; 6,224,450; 6,271,094; 6,295,944; 6,364,278; and 6,391,985; U.S. Patent Applications Publication Nos. 2007/0150036; 2009/0187222; 2009/0276021; 2010/0076535; 2010/0268298; 2011/0004267; 2011/0078900; 2011/0130817; 2011/0130818; 2011/0238129; 2011/0313500; 2012/0016378; 2012/0046710; 2012/0071949; 2012/0165911; 2012/0197375; 2012/0203316; 2012/0203320; 2012/0203321; 2012/0316615; and 2013/0105071; and U.S. patent application Ser. Nos. 12/177,823 and 13/750,725, all of which are incorporated by reference in their entireties. Examples of implanting or anchoring leads may be found in U.S. Pat. Nos. 8,019,443; 8,718,790; 8,768,488; 8,849,422; and U.S. Patent Publication Nos. 2012/0185027; 2013/01317518, which are incorporated by reference in their entireties.
It will be understood that the electrical stimulation system can include more, fewer, or different components and can have a variety of different configurations including those configurations disclosed in the electrical stimulation system references cited herein. For example, instead of a paddle body, the electrodes can be disposed in an array at or near the distal end of a lead body forming a percutaneous lead.
The lead 103 can be coupled to the control module 102 in any suitable manner. In
In
With reference to
The electrical stimulation system or components of the electrical stimulation system, including the paddle body 104, the one or more of the lead bodies 106, and the control module 102, are typically implanted into the body of a patient. The electrical stimulation system can be used for a variety of applications including, but not limited to deep brain stimulation, neural stimulation, spinal cord stimulation, muscle stimulation, and the like.
The electrodes 134 can be formed using any conductive, biocompatible material. Examples of suitable materials include metals, alloys, conductive polymers, conductive carbon, and the like, as well as combinations thereof. In at least some embodiments, one or more of the electrodes 134 are formed from one or more of: platinum, platinum iridium, palladium, palladium rhodium, or titanium.
Any suitable number of electrodes 134 can be disposed on the lead including, for example, four, five, six, seven, eight, nine, ten, eleven, twelve, fourteen, sixteen, twenty-four, thirty-two, or more electrodes 134. In the case of paddle leads, the electrodes 134 can be disposed on the paddle body 104 in any suitable arrangement. In
The electrodes of the paddle body 104 (or one or more lead bodies 106) are typically disposed in, or separated by, a non-conductive, biocompatible material such as, for example, silicone, polyurethane, polyetheretherketone (“PEEK”), epoxy, and the like or combinations thereof. The one or more lead bodies 106 and, if applicable, the paddle body 104 may be formed in the desired shape by any process including, for example, molding (including injection molding), casting, and the like. The non-conductive material typically extends from the distal ends of the one or more lead bodies 106 to the proximal end of each of the one or more lead bodies 106.
In the case of paddle leads, the non-conductive material typically extends from the paddle body 104 to the proximal end of each of the one or more lead bodies 106. Additionally, the non-conductive, biocompatible material of the paddle body 104 and the one or more lead bodies 106 may be the same or different. Moreover, the paddle body 104 and the one or more lead bodies 106 may be a unitary structure or can be formed as two separate structures that are permanently or detachably coupled together.
Terminals (e.g., 310 in
The electrically conductive wires (“conductors”) may be embedded in the non-conductive material of the lead body 106 or can be disposed in one or more lumens (not shown) extending along the lead body 106. In some embodiments, there is an individual lumen for each conductor. In other embodiments, two or more conductors extend through a lumen. There may also be one or more lumens (not shown) that open at, or near, the proximal end of the one or more lead bodies 106, for example, for inserting a stylet to facilitate placement of the one or more lead bodies 106 within a body of a patient. Additionally, there may be one or more lumens (not shown) that open at, or near, the distal end of the one or more lead bodies 106, for example, for infusion of drugs or medication into the site of implantation of the one or more lead bodies 106. In at least one embodiment, the one or more lumens are flushed continually, or on a regular basis, with saline, epidural fluid, or the like. In at least some embodiments, the one or more lumens are permanently or removably sealable at the distal end.
The control module connector 144 defines at least one port into which a proximal end of the elongated device 300 can be inserted, as shown by directional arrows 312a and 312b. In
The control module connector 144 also includes a plurality of connector contacts, such as connector contact 314, disposed within each port 304a and 304b. When the elongated device 300 is inserted into the ports 304a and 304b, the connector contacts 314 can be aligned with a plurality of terminals 310 disposed along the proximal end(s) of the elongated device(s) 300 to electrically couple the control module 102 to the electrodes (134 of
A lead extension connector 322 is disposed on the lead extension 324. In
In at least some embodiments, the proximal end of the lead extension 324 is similarly configured and arranged as a proximal end of the lead 103 (or other elongated device 300). The lead extension 324 may include a plurality of electrically conductive wires (not shown) that electrically couple the connector contacts 340 to a proximal end 348 of the lead extension 324 that is opposite to the distal end 326. In at least some embodiments, the conductive wires disposed in the lead extension 324 can be electrically coupled to a plurality of terminals (not shown) disposed along the proximal end 348 of the lead extension 324. In at least some embodiments, the proximal end 348 of the lead extension 324 is configured and arranged for insertion into a connector disposed in another lead extension (or another intermediate device). In other embodiments (and as shown in
The following embodiments of the present invention describe a paddle-style lead, a helical lead, or some combination of both. One or both of the leads can be used for any type of electrostimulation (e.g., neurostimulation, neuromodulation or some other type of electrostimulation). For example, the lead can be used for stimulation of a target tissue such as a target nerve or target organ, and more specifically such as peripheral targets that may include, but are not limited to, peripheral nerves, the sympathetic chain/trunk, the adrenal gland, and other nerves or stimulation targets that may be rather close to a surface of a patient's skin. In at least some embodiments, one or both leads may be implanted in unconstrained environments, so the embodiments described herein provide structures and methods to secure or anchor the leads to the patient's tissue in a vicinity of the target tissue. The paddle-style lead employs active or positive tissue-engagement elements or devices while the helical lead employs a shape and implantation method that permits the helical lead to be wrapped or coiled around the target. In at least some embodiments, the tissue-engagement elements or devices provide for dimensional stability along a longitudinal axis and a lateral axis of the paddle-style lead. The following embodiments may be combined with any of the aspects or features of the aforementioned embodiments.
As described above with respect to
The electrodes 404 can be made from any conductive, biocompatible material. Examples of suitable materials include metals, alloys, conductive polymers, conductive carbon, and the like, as well as combinations thereof. In at least some embodiments, one or more of the electrodes 404 are formed from one or more of: platinum, platinum iridium, palladium, palladium rhodium, titanium, stainless steel, or any other suitable biocompatible conductive material (e.g., a conductive polymer). Additionally or alternatively, the electrodes 404 may be coated with a second conductive material that exhibits preferred chemical, electrochemical, or physical properties such as, but not limited to, iridium, iridium oxide, or titanium nitride.
The paddle body 402 can be made from a non-conductive, biocompatible material such as, for example, silicone, polyurethanes (PU), polyetheretherketone (“PEEK”), polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), polyisobutylene polyurethane (PIB-PUR), poly (styrene-block-isobutylene-block-styrene) (SIBS), epoxy, any other suitable biocompatible material, and any combinations thereof. Additionally or alternatively and with respect to the paddle body 402, the lead body 406, the protuberances 408, or both may be made from similar materials, a similar combination or a different material or materials as the paddle body 402.
The paddle-style lead 400 further includes one or more anchoring devices 414. Each anchoring device includes a head element 416 coupled to a tissue-engagement element 418. In the illustrated embodiment, the anchoring device 414 extends through both the paddle body 402 and the protuberance 408. In other embodiments, the anchoring device 414 may extend only through the paddle body 402 or may extend only through the protuberance 408. The head element 416 may take the form of a fastener head having a recess portion, described in more detail with respect to
In at least some embodiments, the head element 416 and the tissue-engagement element 418 are made from stainless steel. However, these elements 416, 418 can be made from a different material such as materials used for the electrodes or other materials such as MP35N, titanium, rigid plastics or the like. Additionally or alternatively, the head element 416 can made from a different material than the tissue-engagement element 418 or vice-versa.
In at least some embodiments, the paddle-style lead 400 includes two or more tissue-engagement elements 418 that are each contained within the paddle body 402 prior to implantation. The two or more tissue-engagement elements may be configured such that they are not able to fully disengage from the paddle (e.g., not able to back out completely), such that it is not possible for the engagement element to become “lost” in a patient.
Additionally or alternatively, the head element may be protected with a plug or septum, such as a slit polymer plug or a silicone seal plug, that keeps tissue from growing in and around the head element. The plug may be similar to the plugs that are used in many pulse generator headers around set screws that engage a lead terminal.
The illustrated embodiment of
In at least some embodiments, the curved paddle body 602 may be tailored for a specific tissue, nerve or organ size, or in some cases, be tailored to be patient-specific to match an anatomy size found during pre-operative imaging. While the illustrated, curved paddle body 602 is shown to be curved about the long axis, it is appreciated that the curved paddle body may also be curved about the short axis (e.g., to curve around an organ).
Referring to
The head element 616 may take the form of a socket head or hex socket having a recessed portion 620 configured to receive or engage with a tool (not shown). In the illustrated embodiment, the head element comprises a recessed portion 620 having a hexagonal configuration for receiving tool, which may take the form of a hex key, hex wrench or Allen wrench. In at least some other embodiments, the head element 616 may have a different configuration for engagement with a different type of torque-application tool. By way of example, the head element may take the form of a flathead, Philips, square, or star-shape pattern.
Referring to
In at least some embodiments, inserting the stylet 708 causes the distal end portion of the lead 700 to have a helical shape. It will be understood that the lead can be bent into other shapes using the stylet 708. In at least some embodiments, the stylet 708 is inserted through the lumen 706 that extends along at least a portion of the lead including, preferably, the distal end portion of the lead 700. It will also be understood that more than one guidewire or stylet can be used and may be inserted into the same lumen or different lumens within the lead. In at least some embodiment, the stylet 708 may have an amount of stiffness that allows it to be delivered along the target tissue 701 by rotating the lead 700 with the stylet 708 inserted such that the lead 700 is forced to “corkscrew” around the target tissue 701. In at least some embodiments, the stylet 708 is made from nitinol, but it is appreciated that other materials may be used for the stylet.
In at least some embodiments, the lead body 702 may be molded to have a loose helical shape before insertion or retraction of the stylet 708 while the stylet 708 is straight when inserted into the lumen 706. Insertion of the stylet 708 causes the lead 700 to straighten and removal of the stylet 708 causes the lead 700 to take on the helical shape or twist. In at least some other embodiments, the stylet 708 has a helical shape and causes a straight lead to take on the helical shape before insertion into or after retraction of the stylet 708 from the lumen 706.
In at least some embodiments, the stylet 708 may remain in the lead 700 after implantation to retain the helical or other shape of the distal end of the lead 700. In other embodiments, the stylet 708 may be removed after implantation and the distal end of the lead 700 is arranged to maintain the helical or other shape on its own.
In at least some embodiments, deployment or retraction of the tissue-engagement devices 806, 810 may be accomplished by using a tool, such as forceps, to translate or otherwise urge the tissue-engagement devices 806, 810 out of or back into the paddle body 802 as indicated by arrow 814. In other embodiments, a mechanism (not shown) coupled to a proximal end of the lead 800 may be used to deploy or retract the tissue-engagement devices 806, 810. The mechanism may be manipulated, rotated or otherwise actuated to cause the tissue-engagement devices 806, 810 to deploy or retract from the paddle body 802.
If the power source 1088 is a rechargeable battery or chargeable capacitor, the power source may be recharged/charged using the antenna 1090, if desired. Power can be provided for recharging/charging by inductively coupling the power source 1088 through the antenna 1090 to a recharging unit 1096 external to the user. Examples of such arrangements can be found in the references identified above.
In one embodiment, electrical current is emitted by the electrodes (such as electrodes 134 in
Any processor can be used and can be as simple as an electronic device that, for example, produces pulses at a regular interval or the processor can be capable of receiving and interpreting instructions from an external programming unit 1098 that, for example, allows modification of pulse characteristics. In the illustrated embodiment, the processor 1094 is coupled to a receiver 1092 which, in turn, is coupled to the antenna 1090. This allows the processor 1094 to receive instructions from an external source to, for example, direct the pulse characteristics and the selection of electrodes, if desired.
In one embodiment, the antenna 1090 is capable of receiving signals (e.g., RF signals) from an external telemetry unit 1099 that is programmed by the programming unit 1098. The programming unit 1098 can be external to, or part of, the telemetry unit 1099. The telemetry unit 1099 can be a device that is worn on the skin of the user or can be carried by the user and can have a form similar to a pager, cellular phone, or remote control, if desired. As another alternative, the telemetry unit 1099 may not be worn or carried by the user but may only be available at a home station or at a clinician's office. The programming unit 1098 can be any unit that can provide information to the telemetry unit 1099 for transmission to the electrical stimulation system 1082. The programming unit 1098 can be part of the telemetry unit 1099 or can provide signals or information to the telemetry unit 1099 via a wireless or wired connection. One example of a suitable programming unit is a computer operated by the user or clinician to send signals to the telemetry unit 1099.
The signals sent to the processor 1094 via the antenna 1090 and the receiver 1092 can be used to modify or otherwise direct the operation of the electrical stimulation system 1082. For example, the signals may be used to modify the pulses of the electrical stimulation system such as modifying one or more of pulse duration, pulse frequency, pulse waveform, and pulse strength. The signals may also direct the electrical stimulation system 1082 to cease operation, to start operation, to start charging the battery, or to stop charging the battery.
Optionally, the electrical stimulation system 1082 may include a transmitter (not shown) coupled to the processor 1094 and the antenna 1090 for transmitting signals back to the telemetry unit 1099 or another unit capable of receiving the signals. For example, the electrical stimulation system 1082 may transmit signals indicating whether the electrical stimulation system 1082 is operating properly or not or indicating when the battery needs to be charged or the level of charge remaining in the battery. The processor 1094 may also be capable of transmitting information about the pulse characteristics so that a user or clinician can determine or verify the characteristics.
The above specification provides a description of the structure, manufacture, and use of the invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, the invention also resides in the claims hereinafter appended.
This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 62/344,839, filed Jun. 2, 2016, which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3769984 | Muench | Nov 1973 | A |
3941136 | Bucalo | Mar 1976 | A |
4033357 | Helland et al. | Jul 1977 | A |
4135518 | Dutcher | Jan 1979 | A |
4257428 | Barton et al. | Mar 1981 | A |
4301815 | Doring | Nov 1981 | A |
4409994 | Doring | Oct 1983 | A |
4475560 | Tarjan et al. | Oct 1984 | A |
4506679 | Mann | Mar 1985 | A |
4542753 | Brenman et al. | Sep 1985 | A |
4573481 | Bullara | Mar 1986 | A |
4585005 | Lue et al. | Apr 1986 | A |
4628944 | MacGregor et al. | Dec 1986 | A |
4702254 | Zabara | Oct 1987 | A |
4716888 | Wesner | Jan 1988 | A |
4722353 | Sluetz | Feb 1988 | A |
4796643 | Nakazawa et al. | Jan 1989 | A |
4867164 | Zabara | Sep 1989 | A |
4920979 | Bullara | May 1990 | A |
4934368 | Lynch | Jun 1990 | A |
4957118 | Erlebacher | Sep 1990 | A |
5025807 | Zabara | Jun 1991 | A |
5095905 | Klepinski | Mar 1992 | A |
5139539 | Haynes, Jr. | Aug 1992 | A |
5143067 | Rise et al. | Sep 1992 | A |
5193539 | Schulman et al. | Mar 1993 | A |
5193540 | Schulman et al. | Mar 1993 | A |
5239540 | Rovira et al. | Aug 1993 | A |
5251634 | Weinberg | Oct 1993 | A |
5257634 | Kroll | Nov 1993 | A |
5282468 | Klepinski | Feb 1994 | A |
5312439 | Loeb | May 1994 | A |
5314457 | Jeutter et al. | May 1994 | A |
5324322 | Grill et al. | Jun 1994 | A |
5324327 | Cohen | Jun 1994 | A |
5376108 | Collins et al. | Dec 1994 | A |
5405367 | Schulman et al. | Apr 1995 | A |
5433735 | Zanakis et al. | Jul 1995 | A |
5439938 | Snyder et al. | Aug 1995 | A |
5454840 | Krakovsky et al. | Oct 1995 | A |
5480420 | Hoegnelid et al. | Jan 1996 | A |
5487756 | Kallesoe et al. | Jan 1996 | A |
5531781 | Alferness et al. | Jul 1996 | A |
5571118 | Boutos | Nov 1996 | A |
5741319 | Woloszko et al. | Apr 1998 | A |
5755762 | Bush | May 1998 | A |
5775331 | Raymond et al. | Jul 1998 | A |
5876399 | Chia et al. | Mar 1999 | A |
5919220 | Stieglitz et al. | Jul 1999 | A |
5922015 | Schaldach et al. | Jul 1999 | A |
5938584 | Ardito et al. | Aug 1999 | A |
6051017 | Loeb et al. | Apr 2000 | A |
6058332 | Dahl | May 2000 | A |
6061596 | Richmond et al. | May 2000 | A |
6151526 | Tziviskos | Nov 2000 | A |
6175710 | Kamaji et al. | Jan 2001 | B1 |
6175764 | Loeb et al. | Jan 2001 | B1 |
6181965 | Loeb et al. | Jan 2001 | B1 |
6181969 | Fielding et al. | Jan 2001 | B1 |
6181973 | Ceron et al. | Jan 2001 | B1 |
6185452 | Schulman et al. | Feb 2001 | B1 |
6185455 | Loeb et al. | Feb 2001 | B1 |
6188932 | Lindegren | Feb 2001 | B1 |
6201994 | Warman et al. | Mar 2001 | B1 |
6214032 | Loeb et al. | Apr 2001 | B1 |
6224450 | Norton | May 2001 | B1 |
6271094 | Boyd et al. | Aug 2001 | B1 |
6278897 | Rutten et al. | Aug 2001 | B1 |
6292703 | Meier et al. | Sep 2001 | B1 |
6295944 | Lovett | Oct 2001 | B1 |
6308105 | Duysens et al. | Oct 2001 | B1 |
6315721 | Schulman et al. | Nov 2001 | B2 |
6364278 | Lin et al. | Apr 2002 | B1 |
6391985 | Goode et al. | May 2002 | B1 |
6456866 | Tyler et al. | Sep 2002 | B1 |
6463335 | Munch et al. | Oct 2002 | B1 |
6516227 | Meadows et al. | Feb 2003 | B1 |
6582441 | He et al. | Jun 2003 | B1 |
6584363 | Heil, Jr. et al. | Jun 2003 | B2 |
6609029 | Mann et al. | Aug 2003 | B1 |
6609032 | Woods et al. | Aug 2003 | B1 |
6643546 | Mathis et al. | Nov 2003 | B2 |
6650943 | Whitehurst et al. | Nov 2003 | B1 |
6735474 | Loeb et al. | May 2004 | B1 |
6741892 | Meadows et al. | May 2004 | B1 |
6788975 | Whitehurst et al. | Sep 2004 | B1 |
7003352 | Whitehurst | Feb 2006 | B1 |
7006875 | Kuzma et al. | Feb 2006 | B1 |
7203548 | Whitehurst et al. | Apr 2007 | B2 |
7244150 | Brase et al. | Jul 2007 | B1 |
7248930 | Woloszko et al. | Jul 2007 | B1 |
7292890 | Whitehurst et al. | Nov 2007 | B2 |
7437193 | Parramon et al. | Oct 2008 | B2 |
7450997 | Pianca et al. | Nov 2008 | B1 |
7460913 | Kuzma et al. | Dec 2008 | B2 |
7584004 | Caparso et al. | Sep 2009 | B2 |
7596414 | Whitehurst et al. | Sep 2009 | B2 |
7610103 | Whitehurst et al. | Oct 2009 | B2 |
7672734 | Anderson et al. | Mar 2010 | B2 |
7706892 | Colvin et al. | Apr 2010 | B2 |
7761165 | He et al. | Jul 2010 | B1 |
7783359 | Meadows | Aug 2010 | B2 |
7783362 | Whitehurst et al. | Aug 2010 | B2 |
7792590 | Pianca et al. | Sep 2010 | B1 |
7809446 | Meadows | Oct 2010 | B2 |
7840279 | He | Nov 2010 | B2 |
7949395 | Kuzma | May 2011 | B2 |
7953498 | Carbunaru et al. | May 2011 | B1 |
7974706 | Moffitt et al. | Jul 2011 | B2 |
8019443 | Schleicher et al. | Sep 2011 | B2 |
8155757 | Neisz et al. | Apr 2012 | B1 |
8175710 | He | May 2012 | B2 |
8224450 | Brase | Jul 2012 | B2 |
8271094 | Moffitt et al. | Sep 2012 | B1 |
8295944 | Howard et al. | Oct 2012 | B2 |
8364278 | Pianca et al. | Jan 2013 | B2 |
8391985 | McDonald | Mar 2013 | B2 |
8483237 | Zimmermann et al. | Jul 2013 | B2 |
8594805 | Hincapie Ordonez et al. | Nov 2013 | B2 |
8612025 | Neisz et al. | Dec 2013 | B2 |
8688235 | Pianca et al. | Apr 2014 | B1 |
8718790 | Pianca | May 2014 | B2 |
8768488 | Barker | Jul 2014 | B2 |
8818524 | Hincapie Ordonez et al. | Aug 2014 | B2 |
8831742 | Pianca et al. | Sep 2014 | B2 |
8849422 | Pianca | Sep 2014 | B2 |
8934992 | Johnson et al. | Jan 2015 | B2 |
20030040785 | Maschino et al. | Feb 2003 | A1 |
20030045919 | Swoyer et al. | Mar 2003 | A1 |
20030074039 | Puskas | Apr 2003 | A1 |
20030078623 | Weinberg et al. | Apr 2003 | A1 |
20030114905 | Kuzma | Jun 2003 | A1 |
20030199938 | Smits et al. | Oct 2003 | A1 |
20030236558 | Whitehurst et al. | Dec 2003 | A1 |
20040010303 | Bolea et al. | Jan 2004 | A1 |
20040034401 | Dahlberg et al. | Feb 2004 | A1 |
20040059392 | Parramon et al. | Mar 2004 | A1 |
20040111139 | McCreery | Jun 2004 | A1 |
20040230280 | Cates et al. | Nov 2004 | A1 |
20050010265 | Baru Fassio et al. | Jan 2005 | A1 |
20050065589 | Schneider et al. | Mar 2005 | A1 |
20050177220 | Iaizzo et al. | Aug 2005 | A1 |
20050182472 | Wahlstrom et al. | Aug 2005 | A1 |
20060161204 | Colvin et al. | Jul 2006 | A1 |
20060173522 | Osorio | Aug 2006 | A1 |
20060184204 | He | Aug 2006 | A1 |
20060212075 | Marnfeldt | Sep 2006 | A1 |
20060241737 | Tockman et al. | Oct 2006 | A1 |
20060282145 | Caparso et al. | Dec 2006 | A1 |
20070150036 | Anderson | Jun 2007 | A1 |
20070219595 | He | Sep 2007 | A1 |
20080046055 | Durand et al. | Feb 2008 | A1 |
20080071320 | Brase | Mar 2008 | A1 |
20090187222 | Barker | Jul 2009 | A1 |
20090276021 | Meadows et al. | Nov 2009 | A1 |
20090287271 | Blum et al. | Nov 2009 | A1 |
20090287272 | Kokones et al. | Nov 2009 | A1 |
20090287273 | Carlton et al. | Nov 2009 | A1 |
20090287467 | Sparks et al. | Nov 2009 | A1 |
20100049276 | Blum et al. | Feb 2010 | A1 |
20100076535 | Pianca et al. | Mar 2010 | A1 |
20100241207 | Bluger | Sep 2010 | A1 |
20100268298 | Moffitt et al. | Oct 2010 | A1 |
20100298916 | Rabischong et al. | Nov 2010 | A1 |
20110004267 | Meadows et al. | Jan 2011 | A1 |
20110005069 | Pianca | Jan 2011 | A1 |
20110078900 | Pianca et al. | Apr 2011 | A1 |
20110130803 | McDonald | Jun 2011 | A1 |
20110130817 | Chen | Jun 2011 | A1 |
20110130818 | Chen | Jun 2011 | A1 |
20110238129 | Moffitt et al. | Sep 2011 | A1 |
20110313500 | Barker et al. | Dec 2011 | A1 |
20120016378 | Pianca et al. | Jan 2012 | A1 |
20120046710 | Digiore et al. | Feb 2012 | A1 |
20120071949 | Pianca et al. | Mar 2012 | A1 |
20120165911 | Pianca | Jun 2012 | A1 |
20120185027 | Pianca et al. | Jul 2012 | A1 |
20120197375 | Pianca et al. | Aug 2012 | A1 |
20120203316 | Moffitt et al. | Aug 2012 | A1 |
20120203320 | Digiore et al. | Aug 2012 | A1 |
20120203321 | Moffitt et al. | Aug 2012 | A1 |
20120316615 | Digiore et al. | Dec 2012 | A1 |
20130023974 | Amrani | Jan 2013 | A1 |
20130105071 | Digiore et al. | May 2013 | A1 |
20130172973 | Tockman et al. | Jul 2013 | A1 |
20130197424 | Bedenbaugh | Aug 2013 | A1 |
20130197602 | Pianca et al. | Aug 2013 | A1 |
20130261684 | Howard | Oct 2013 | A1 |
20130317518 | Govea | Nov 2013 | A1 |
20130317587 | Barker | Nov 2013 | A1 |
20130325091 | Pianca et al. | Dec 2013 | A1 |
20140039587 | Romero | Feb 2014 | A1 |
20140074213 | Neisz et al. | Mar 2014 | A1 |
20140277284 | Chen et al. | Sep 2014 | A1 |
20140353001 | Romero et al. | Dec 2014 | A1 |
20140358207 | Romero | Dec 2014 | A1 |
20140358209 | Romero et al. | Dec 2014 | A1 |
20140358210 | Howard et al. | Dec 2014 | A1 |
20150018915 | Leven | Jan 2015 | A1 |
20150021817 | Romero et al. | Jan 2015 | A1 |
20150045864 | Howard | Feb 2015 | A1 |
20150066120 | Govea | Mar 2015 | A1 |
20150119965 | Govea | Apr 2015 | A1 |
20150151113 | Govea et al. | Jun 2015 | A1 |
20150202433 | Franke et al. | Jul 2015 | A1 |
20150202446 | Franke et al. | Jul 2015 | A1 |
20150366467 | De Kock et al. | Dec 2015 | A1 |
20170224982 | Nageri et al. | Aug 2017 | A1 |
Number | Date | Country |
---|---|---|
9837926 | Sep 1998 | WO |
9843700 | Oct 1998 | WO |
9843701 | Oct 1998 | WO |
2008019483 | Feb 2008 | WO |
2008048471 | Apr 2008 | WO |
2013188871 | Dec 2013 | WO |
Entry |
---|
Rattay, F., “Analysis of Models for External Stimulation of Axons,” IEEE Transactions on Biomedical Engineering, BME-33(10): 974-977, 1986. |
U.S. Appl. No. 15/601,838, filed May 22, 2017. |
U.S. Appl. No. 15/436,544, filed Feb. 17, 2017. |
U.S. Appl. No. 62/429,650, filed Dec. 2, 2016. |
U.S. Appl. No. 15/656,734, filed Jul. 21, 2017. |
Rozman et al., “Selective Stimulation of Autonomic Nerves and Recording of Electroneurograms in a Canine Model,” Artificiai Organs, 21(8): 592-595. 2008. |
Polasek et al., “Stimulation Stability and Selectivity of Chronically Implanted Multicontact Nerve Cuff Electrodes in the Human Upper Extremity,” IEEE Transactions on Neural Systems and Rehabilitation Engineering. vol. 17, No. 5, 428-437, Oct. 2009. |
Plachta et al., “Blood pressure control with selective vagal nerve stimulation and minimal side effects,” J. Neural Eng. 11 (2014) 036011 (15pp), 2014. |
Number | Date | Country | |
---|---|---|---|
20170348522 A1 | Dec 2017 | US |
Number | Date | Country | |
---|---|---|---|
62344839 | Jun 2016 | US |